Liu, C., Armstrong, C. M., Lou, W., Lombard, A., Evans, C. P., & Gao, A. C. (2016). Inhibition of AKR1C3 activation overcomes resistance to abiraterone in advanced prostate cancer. Mol Cancer Ther.
Chicago Stili AlıntıLiu, Chengfei, Cameron M. Armstrong, Wei Lou, Alan Lombard, Christopher P. Evans, ve Allen C. Gao. "Inhibition of AKR1C3 Activation Overcomes Resistance to Abiraterone in Advanced Prostate Cancer." Mol Cancer Ther 2016.
MLA AlıntıLiu, Chengfei, et al. "Inhibition of AKR1C3 Activation Overcomes Resistance to Abiraterone in Advanced Prostate Cancer." Mol Cancer Ther 2016.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..